Medpace is attending the ERS Congress in Barcelona to connect with respiratory experts Puneet Agarwal and Cinzia Giansante to discuss program acceleration.
Public source
Publisher name
Public post
Heading to ERS Congress in Barcelona? Connect with Medpace #respiratory experts Puneet Agarwal and Cinzia Giansante to discuss how we can accelerate your next program. A…
Company
Medpace
Accelerating Drug, Biologic and Medical Device Clinical Development
- Industry
- Pharmaceutical Manufacturing
- Location
- Cincinnati, US
- Company size
- 5,001–10,000 employees
About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,500 people across 46 countries.
See moreLatest activity
Latest activity from Medpace
9 signals
Presence & Recognition
Medpace has been named a finalist for the 2026 Society for Clinical Research Sites (SCRS) Eagle Award
Research & Knowledge
Medpace executed a case study on Duchenne Muscular Dystrophy clinical trials, highlighting how Medpace executes DMD trials seamlessly.
Presence & Recognition
Medpace Poland team competed in their annual office park volleyball tournament and took home first place
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Syneos Health
Syneos Health team is attending the ERS2026 congress in Barcelona to discuss respiratory research, clinical development, and new treatments.
Presence & Recognition
GSK
GSK is attending the ERSCongress to meet global experts and shape the future of respiratory medicine with its pipeline targeting key inflammatory pathways of respiratory disease with longer-acting solutions.
Presence & Recognition
NS Pharma, Inc.
NS Pharma, Inc. is attending the European Respiratory Society International Congress in Barcelona for the 2026 event.
Presence & Recognition
Trialbee
Trialbee is presenting a panel discussion at DPHARM26 exploring how to transform recruitment efforts into a scalable, research-ready patient community through active recruitment campaigns across therapeutic areas.
Presence & Recognition
AstraZeneca